tirzepatide additives Compounded for Weight Loss: What to Know Clinical Guide To Building A

5 Mounjaro (Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, & 15 mg) subcutaneous injection, Rx only, has not been approved by the FDA as safe and effective to treat obesity or overweight, however studies have shown that it may be associated with weight loss in individuals with type 2 diabetes

If you have relative contraindications or a complex medical history, PlexusDx genetic insights can complement your provider's clinical assessment

Get in touch if you are a prescriber or provider of hormonal medications and are interested in learning more about our technology

doi: 10.1016/j.lfs.2020.118645 [DOI] [PubMed] [Google Scholar] 139

It's fairly rare in patients because we're microdosing